Ablynx NV
Latest round
- Series C
Last raised
- Aug 2006
Total raised
- $86M
Investors
- 9
About Ablynx NV
Ablynx NV, founded in 2001, is located in Ghent, Belgium. The company focuses on developing therapies using its NANOBODY technology.00 mn.Ablynx's NANOBODY® Technology Platform centers on creating therapeutic compounds from specialized proteins known as antibodies. These engineered NANOBODY molecules, derived from unique heavy-chain-only antibodies found in species like camels and llamas, are capable of binding multiple targets, enhancing efficacy in oncology and immunology.Ablynx NV is focused on expanding its product pipeline and enhancing its market presence. Upcoming launches of new NANOBODY therapies are anticipated, with timelines yet to be announced. The company seeks to penetrate additional geographic markets, targeting regions in Asia and Europe.
Who invested in Ablynx NV
9 investors across 3 rounds
See all investors in Ablynx NV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ablynx NV
Who invested in Ablynx NV?
Ablynx NV has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ablynx NV raised?
Ablynx NV has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ablynx NV last raise money?
Ablynx NV's most recent round on record is a Series C, in Aug 2006.
What does Ablynx NV do?
Ablynx NV, founded in 2001, is located in Ghent, Belgium.
Where is Ablynx NV headquartered?
Ablynx NV is headquartered in Ghent, Belgium.
Which VCs invest in companies like Ablynx NV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Ablynx NV's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Ablynx NV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.